Athira Pharma Statistics

Total Valuation

Athira Pharma has a market cap or net worth of $15.22 million. The enterprise value is -$13.58 million.

Market Cap	15.22M
Enterprise Value	-13.58M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Athira Pharma has 3.94 million shares outstanding. The number of shares has increased by 1.64% in one year.

Current Share Class	3.94M
Shares Outstanding	3.94M
Shares Change (YoY)	+1.64%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	13.95%
Owned by Institutions (%)	22.82%
Float	2.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.48
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.81, with a Debt / Equity ratio of 0.03.

Current Ratio	10.81
Quick Ratio	10.00
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -103.80% and return on invested capital (ROIC) is -61.45%.

Return on Equity (ROE)	-103.80%
Return on Assets (ROA)	-49.29%
Return on Invested Capital (ROIC)	-61.45%
Return on Capital Employed (ROCE)	-177.76%
Revenue Per Employee	n/a
Profits Per Employee	-$2.30M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.65% in the last 52 weeks. The beta is 3.02, so Athira Pharma's price volatility has been higher than the market average.

Beta (5Y)	3.02
52-Week Price Change	-11.65%
50-Day Moving Average	3.96
200-Day Moving Average	3.88
Relative Strength Index (RSI)	48.94
Average Volume (20 Days)	40,271

Short Selling Information

The latest short interest is 961,269, so 24.37% of the outstanding shares have been sold short.

Short Interest	961,269
Short Previous Month	842,751
Short % of Shares Out	24.37%
Short % of Float	37.99%
Short Ratio (days to cover)	5.78

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-57.89M
Pretax Income	-59.85M
Net Income	-59.85M
EBITDA	-56.92M
EBIT	-57.89M
Earnings Per Share (EPS)	-$15.41

Full Income Statement

Balance Sheet

The company has $29.82 million in cash and $1.02 million in debt, giving a net cash position of $28.81 million or $7.30 per share.

Cash & Cash Equivalents	29.82M
Total Debt	1.02M
Net Cash	28.81M
Net Cash Per Share	$7.30
Equity (Book Value)	31.99M
Book Value Per Share	8.11
Working Capital	29.24M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-70.70M
Capital Expenditures	n/a
Free Cash Flow	-70.70M
FCF Per Share	-$17.93

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Athira Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.64%
Shareholder Yield	-1.64%
Earnings Yield	-393.16%
FCF Yield	-464.41%

Analyst Forecast

The average price target for Athira Pharma is $5.00, which is 29.53% higher than the current price. The consensus rating is "Hold".

Price Target	$5.00
Price Target Difference	29.53%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 18, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Sep 18, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1